Title
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019.
Performers
Hearing witnesses: Lou Kennedy, Chief Executive Officer and Owner, Nephron Pharmaceuticals; Chester ``Chip'' Davis, Jr., President and Chief Executive Officer, Association for Accessible Medicines; Anthony A. Barrueta, Senior Vice President, Government Relations, Kaiser Permanente; Marc M. Boutin, Chief Executive Officer, National Health Council; Kurt R. Karst, Director, Hyman, Phelps and McNamara, P. C; Jeffrey P. Kushan, Partner, Sidley Austin, LLP; Michael A. Carrier, Distinguished Professor, Rutgers Law School.